Number of Patients by Best Clinical Response At Completion of Course 3 (Day 63) [clinicaltrials_resource:13433ead4d3f8ea93da756d3cc946e7c]
Assessed by the International Working Group response criteria: Categories include Complete Remission (CR), Partial Remission (PR), Marrow CR, Hematologic Improvement (HI), Stable Disease, Cytogenic Response and Disease Progression. clinical response = CR+PR+HI. Thus, all patients who complete at least 1 full cycle of therapy will be considered evaluable for response.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of Patients by Best Clinical Response At Completion of Course 3 (Day 63) [clinicaltrials_resource:13433ead4d3f8ea93da756d3cc946e7c]
Assessed by the International Working Group response criteria: Categories include Complete Remission (CR), Partial Remission (PR), Marrow CR, Hematologic Improvement (HI), Stable Disease, Cytogenic Response and Disease Progression. clinical response = CR+PR+HI. Thus, all patients who complete at least 1 full cycle of therapy will be considered evaluable for response.
Bio2RDF identifier
13433ead4d3f8ea93da756d3cc946e7c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:13433ead4d3f8ea93da756d3cc946e7c
measure [clinicaltrials_vocabulary:measure]
Number of Patients by Best Clinical Response
time frame [clinicaltrials_vocabulary:time-frame]
At Completion of Course 3 (Day 63)
description
Assessed by the International ...... idered evaluable for response.
identifier
clinicaltrials_resource:13433ead4d3f8ea93da756d3cc946e7c
title
Number of Patients by Best Clinical Response At Completion of Course 3 (Day 63)
@en
type
label
Number of Patients by Best Cli ...... 33ead4d3f8ea93da756d3cc946e7c]
@en